Century Therapeutics

Filed a patent for "chimeric antigen receptor system with adaptable receptor specificity" on Thu, July 4, 2024

Filed a patent for "engineered interleukin-7 receptors and uses thereof" on Wed, November 9, 2022

Filed a patent for "artificial cell death polypeptide for chimeric antigen receptor and uses thereof" on Thu, November 30, 2023

Filed a patent for "combined artificial cell death/reporter system polypeptide for chimeric antigen receptor cell and uses thereof" on Thu, October 20, 2022

Filed a patent for "compositions and methods for generating alpha-beta t cells from induced pluripotent stem cells" on Thu, October 20, 2022

Filed a patent for "compositions and methods for generating gamma-delta t cells from induced pluripotent stem cells" on Thu, October 20, 2022

Filed a patent for "gene transfer vectors and methods of engineering cells" on Thu, October 20, 2022

Filed a patent for "methods for controlled activation and/or expansion of genetically engineered cells using polyethylene glycol (peg) receptors" on Thu, April 21, 2022

Filed a patent for "cells engineered with an hla-e and hla-g transgene" on Wed, May 4, 2022

Filed a patent for "genetically engineered cells having anti-cd133 / anti-egfr chimeric antigen receptors, and uses thereof" on Wed, June 8, 2022

Filed a patent for "genetically engineered cells expressing cd16 variants and nkg2d and uses thereof" on Wed, June 8, 2022

Filed a patent for "immunoeffector cells derived from induced pluripotent stem cells genetically engineered with membrane bound il12 and uses thereof" on Wed, June 8, 2022

Filed a patent for "genetically engineered cells having anti-cd19 / anti-cd22 chimeric antigen receptors, and uses thereof" on Wed, June 8, 2022